LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.03 | 17.25 | 3638 | 5367 | 0.6778 | 0.9083 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.03 | 17.25 | 12 | 5367 | 0.0022 | -0.0429 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.03 | 17.25 | 3886 | 5367 | 0.7240 | 0.9235 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.00 | 17.25 | 1 | 5546 | 0.0002 | -0.2896 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.00 | 17.25 | 3823 | 5546 | 0.6892 | 0.9126 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.00 | 17.25 | 9 | 5546 | 0.0016 | -0.0752 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.00 | 17.25 | 4071 | 5546 | 0.7339 | 0.9271 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.97 | 17.25 | 4 | 5618 | 0.0007 | -0.1606 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.97 | 17.25 | 3999 | 5618 | 0.7117 | 0.9202 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.97 | 17.25 | 8 | 5618 | 0.0014 | -0.0880 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 74.97 | 17.25 | 4216 | 5618 | 0.7503 | 0.9324 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.94 | 17.25 | 5 | 5681 | 0.0009 | -0.1376 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.94 | 17.25 | 4118 | 5681 | 0.7248 | 0.9245 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.94 | 17.25 | 8 | 5681 | 0.0014 | -0.0878 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.94 | 17.25 | 4433 | 5681 | 0.7802 | 0.9415 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4 | 5730 | 0.0007 | -0.1601 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4343 | 5730 | 0.7579 | 0.9349 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4 | 5730 | 0.0007 | -0.1601 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4576 | 5730 | 0.7985 | 0.9470 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 4 | 5826 | 0.0007 | -0.1597 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 4440 | 5826 | 0.7621 | 0.9363 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 12 | 5826 | 0.0021 | -0.0423 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 4743 | 5826 | 0.8141 | 0.9516 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.85 | 17.25 | 3 | 5861 | 0.0005 | -0.1878 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.85 | 17.25 | 4558 | 5861 | 0.7776 | 0.9411 | MN20160310_N02 | F13 |